Pennington Biomedical Research Center

Quick facts

Marketed products

• Leptin A
• Pioglitazone 45 mg
• sibutramine, orlistat, diethylpropion · Obesity / Weight Management
  This is a combination of three distinct weight-loss medications that work through different mechanisms: sibutramine inhibits norepinephrine and serotonin reuptake, orlistat inhibits pancreatic lipase to reduce fat absorption, and diethylpropion is a sympathomimetic amine that suppresses appetite.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Pennington Biomedical Research Center portfolio CI brief
• Pennington Biomedical Research Center pipeline updates RSS